ReviewOncotarget2017

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.

Young Kwang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.